Welcome to the 9th EAPS Congress Programme Scheduling
The congress will officially run on Barcelona Time (GMT+2)
To convert the congress times to your local time Click Here
- Peter F. Hoyer (Germany)
NEW GUIDELINES FOR MEASURING AND TREATMENT
- Franz Schaefer (Germany)
RISK GROUPS FOR DEVELOPING HYPERTENSION
- Peter F. Hoyer (Germany)
Abstract
Abstract Body
Arterial hypertension has a significant impact on morbidity and mortality in adult patients. In many patients, arterial hypertension begins during childhood. Despite the fact that the prevalence is about 3 % during childhood, it is often not recognized because it is asymptomatic or blood pressure is not taken, and end-organ damage may take time. However, uncontrolled high blood pressure accelerates organ damage.
Therefore, the knowledge of patient groups at risk who might develop arterial hypertension is of utmost importance for early intervention. A prerequisite is the knowledge of the definition of arterial hypertension, how to measure blood pressure in different age groups and the application of normal values.
The risk for the development of arterial hypertension depends on underlying diseases like obesity, parenchymal kidney diseases, renal vascular diseases, kidney failure, dialysis, and transplantation. Some cardiac diseases, endocrine disorders, systemic diseases, and pediatric tumors may be associated with arterial hypertension. Many drugs like glucocorticosteroids, antidepressants, contraceptives, and calcineurin inhibitors increase blood pressure. High salt intake, industrially prepared food, "junk food," as well as energy drinks, and drug abuse should also be considered confounding factors for increased risks for arterial hypertension.
The knowledge of the age prevalence is also helpful for establishing and classifying the correct diagnosis. The underlying causes of arterial hypertension in premature babies and newborns differ significantly from those of older children.
The pathophysiology explaining arterial hypertension will direct the approach for adequate therapy and blood pressure control.